|
?:authorAffiliation
|
-
[\'Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Dr. Emilio Ravignani 2024 C1014CPV, Argentina. Electronic address: aciapponi@iecs.org.ar.\', \'Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Dr. Emilio Ravignani 2024 C1014CPV, Argentina. Electronic address: abardach@iecs.org.ar.\', \'Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Dr. Emilio Ravignani 2024 C1014CPV, Argentina. Electronic address: amazzoni@iecs.org.ar.\', \'Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Dr. Emilio Ravignani 2024 C1014CPV, Argentina.\', \'US Food & Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA. Electronic address: Steven.Anderson@fda.hhs.gov.\', \'Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Dr. Emilio Ravignani 2024 C1014CPV, Argentina. Electronic address: fargento@iecs.org.ar.\', \'National Institute of Allergy and Infectious Diseases, National Institutes of Health, 31 Center Dr # 7A03, Bethesda, MD 20892, USA. Electronic address: karin.bok@nih.gov.\', \'Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Dr. Emilio Ravignani 2024 C1014CPV, Argentina. Electronic address: dcomande@iecs.org.ar.\', \'National Institute of Allergy and Infectious Diseases, 1 Center Dr # 7A03, Bethesda, USA. Electronic address: emily.erbelding@nih.gov.\', \'School of Public Health and Tropical Medicine, Tulane University, 1440 Canal St, New Orleans, LA 70112, USA. Electronic address: egoucher@tulane.edu.\', \'The Vaccine Centre, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK; Vaccines & Immunity Theme, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, Gambia. Electronic address: Beate.Kampmann@lshtm.ac.uk.\', \'Bloomberg School of Public Health, Johns Hopkins University, 7CX5+8W Baltimore, MD, USA. Electronic address: rkarron@jhu.edu.\', \'Baylor College of Medicine, Texas Children\'s Hospital, 6621 Fannin St, Houston, TX 77030, USA. Electronic address: florm@bcm.edu.\', \'The Vaccine Centre, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. Electronic address: Edward.Parker@lshtm.ac.uk.\', \'Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Dr. Emilio Ravignani 2024 C1014CPV, Argentina. Electronic address: fcairoli@iecs.org.ar.\', \'School of Pharmacy and School of Public Health, University of Washington, MM2R+78 Seattle, WA, USA. Electronic address: stergach@uw.edu.\', \'TuBerculosis Vaccine Initiative (TBVI), GHF4+6W Lelystad, the Netherlands. Electronic address: gerald.voss@cepi.net.\', \'School of Public Health and Tropical Medicine, Tulane University, 1440 Canal St, New Orleans, LA 70112, USA. Electronic address: xxiong@tulane.edu.\', \'School of Pharmacy, University of Washington, MM2R+78 Seattle, WA, USA. Electronic address: szaraa@uw.edu.\', \'Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Dr. Emilio Ravignani 2024 C1014CPV, Argentina. Electronic address: mberrueta@iecs.org.ar.\', \'School of Public Health and Tropical Medicine, Tulane University, 1440 Canal St, New Orleans, LA 70112, USA. Electronic address: pbuekens@tulane.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}